XBiotech, Inc (XBIT) Covered Calls

You can sell covered calls on XBiotech, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for XBIT (prices last updated Fri 4:16 PM ET):

XBiotech, Inc (XBIT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
10.94 -0.68 9.64 11.49 166K - 0.4B
Covered Calls For XBiotech, Inc (XBIT)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Apr 18 10 1.05 10.44 -4.2% -54.7%
May 17 10 1.05 10.44 -4.2% -26.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

XBiotech Inc., a pre-market biopharmaceutical company, engages in discovering and developing True Human monoclonal antibodies for treating various diseases. The company's lead product is Xilonix, which is also known as MABp1, a therapeutic antibody that neutralizes interleukin-1 alpha, which has completed Phase III clinical trial in Europe for the treatment of symptomatic and advanced colorectal cancer. It has also investigating its lead product candidate in various clinical trials for other inflammatory conditions, including vascular disease, type II diabetes, acne, psoriasis, pyoderma gangrenosum, and hidradenitis suppurativa, as well as staphylococcus aureus infection, influenza, and clostridium difficile infection diseases. XBiotech, Inc. was founded in 2005 and is headquartered in Austin, Texas.